Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2020800121
Up to date per 15.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2020800121
Title / Product Name
ANTI-TUMOR-KOMBINATIONSTHERAPIE, ANTI-CD19-ANTIKÖRPER UND GAMMA-DELTA-T-ZELLEN UMFASSEND
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2020800121
EP Publication Number
4051710
E-Number
1861015
Language
EN
PCT Number
EP20080494
Publication Date
07.09.2022 A
26.11.2025 B1
Registration Date
26.11.2025
AT Publication Date
15.12.2025
Application Date
30.10.2020
Registration Number
-
Priorities
31.10.2019
EP
19206479
IPC
C07K 16/28 20060101AFI20210508BHEP
Maximum Duration of Protection
30.10.2040
Owner
Incyte Corporation
1801 Augustine Cut-Off
Wilmington, DE 19803
US
Representative
No representatives present
Inventor
ENDELL, Jan
Barer Str. 36
80333 München
DE
BOXHAMMER, Rainer
Birkenstraße 4a
83059 Kolbermoor
DE
PRETSCHER, Dominik
Schweinfurter Straße 7
97080 Würzburg
DE
Information about Fees
Click here to load the fees
see.ip - Details for ANTI-TUMOR-KOMBINATIONSTHERAPIE, ANTI-CD19-ANTIKÖRPER UND GAMMA-DELTA-T-ZELLEN UMFASSEND